^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    FLT3-ITD mutation + ASXL1 mutation

    i
    Other names: ASXL1, ASXL Transcriptional Regulator 1, Additional Sex Combs Like 1, Transcriptional Regulator, Polycomb Group Protein ASXL1, Additional Sex Combs Like Transcriptional Regulator 1, Additional Sex Combs Like 1 (Drosophila), Putative Polycomb Group Protein ASXL1, Additional Sex Combs-Like Protein 1, KIAA0978, BOPS, MDS, FLT3, Fms Related Tyrosine Kinase 3, Receptor-Type Tyrosine-Protein Kinase FLT3, Stem Cell Tyrosine Kinase 1, Fms-Like Tyrosine Kinase 3, CD135, FLK-2, STK1, Growth Factor Recepto
    Entrez ID:
    2322; 171023
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    3years
    Clinical implication and prognostic significance of FLT3-ITD and ASXL1 mutations in Egyptian AML patients: A singlecenter study. (PubMed, Cancer Biomark)
    FLT3-ITD and ASXL1 gene mutations or their coexistence can predict a poor prognosis in AML patients.
    Clinical • Journal
    |
    FLT3 (Fms-related tyrosine kinase 3) • ASXL1 (ASXL Transcriptional Regulator 1)
    |
    FLT3-ITD mutation • FLT3 mutation • ASXL1 mutation • FLT3-ITD mutation + ASXL1 mutation